NEW YORK CITY, NY / ACCESS Newswire / November 6, 2026 / Amdocs Limited (NASDAQ: DOX) shares fell roughly 30% by market open on November 4, 2026, after the Company disclosed an escalating legal dispute with T-Mobile, a customer that generated nearly one-fifth of its revenue, alongside a fiscal 2027 outlook that projected revenue and earnings declines. If you purchased DOX shares and lost money in this decline, you may be entitled to seek recovery. Investors who suffered losses are encouraged to submit their loss information for a free review. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The Company's November 4, 2026 earnings presentation described a "dispute concerning the recently signed agreement with T-Mobile, which escalated into a legal dispute during the last quarter." The release further indicated that Amdocs and T-Mobile "have both issued notices to one another, asserting that the other party has materially breached one or more of the agreements." Both companies have allegedly threatened termination and/or arbitration.

According to the Form 20-F filed December 15, 2025, T-Mobile accounted for approximately 19.9% of DOX's fiscal 2025 revenue -- roughly one of every five revenue dollars. Levi & Korsinsky is investigating potential securities law violations on behalf of Amdocs investors who lost money in the decline.

Shareholders who lost money on DOX can start a free case review today or call (212) 363-7500.

ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured billions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.

Frequently Asked Questions About the DOX Investigation

Q: Who is conducting the DOX investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased DOX securities. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered billions of dollars for aggrieved investors.

Q: Who is eligible to participate in the DOX investigation? A: Investors who purchased DOX stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: How much did DOX stock drop? A: Shares opened down approximately $19.19, or about 30.74%, to open at a $43.24 per share on November 4, 2026. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.

Q: What do DOX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my DOX shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought DOX and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

Q: What if I live outside the United States? A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

SOURCE: Levi & Korsinsky, LLP